Chaim Lebovits, President & CEO: Brainstorm Cell Therapeutics BCLI Buy · Filed 24/07/31

Trade details

Type: Insider buy
Amount: $7,800
Shares · price: 15,000 sh · $0.52 a share
Held after: 1,164,865 sh
Stock: Brainstorm Cell Therapeutics BCLI
Person: Chaim LebovitsPresident & CEO
Trade date: 24/05/28
Filed: 24/07/31
Days to filing: 64 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +1.3%

Brainstorm Cell Therapeutics trades, last 26 weeks

What else happened in Brainstorm Cell Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/28~24/06/27

Chaim Lebovits's recent trades

Chaim LebovitsPresident & CEO
BuyBrainstorm Cell Therapeutics
Buy
Brainstorm Cell Therapeutics
BCLI
$6,297
1,836 sh
$6,297
Filed 24/10/02
Traded 24/10/01
Chaim LebovitsPresident & CEO
BuyBrainstorm Cell Therapeutics
Buy
Brainstorm Cell Therapeutics
BCLI
$5,060
22,000 sh
$5,060
Filed 24/10/02
Traded 24/09/30
Chaim LebovitsPresident & CEO
BuyBrainstorm Cell Therapeutics
Buy
Brainstorm Cell Therapeutics
BCLI
$16K
25,000 sh
$16K
Filed 24/07/31
Traded 24/05/22
Chaim LebovitsPresident & CEO
BuyBrainstorm Cell Therapeutics
Buy
Brainstorm Cell Therapeutics
BCLI
$14.5K
25,000 sh
$14.5K
Filed 24/07/31
Traded 24/05/21
Chaim LebovitsPresident & CEO
BuyBrainstorm Cell Therapeutics
Buy
Brainstorm Cell Therapeutics
BCLI
$9,400
20,000 sh
$9,400
Filed 24/07/31
Traded 24/05/10